up and up dual action acid reducer and antacid

Generic: famotidine, calcium carbonate, magnesium hydroxide

Labeler: target corporation
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name up and up dual action acid reducer and antacid
Generic Name famotidine, calcium carbonate, magnesium hydroxide
Labeler target corporation
Dosage Form TABLET, CHEWABLE
Routes
ORAL
Active Ingredients

calcium carbonate 800 mg/1, famotidine 10 mg/1, magnesium hydroxide 165 mg/1

Manufacturer
Target Corporation

Identifiers & Regulatory

Product NDC 82442-546
Product ID 82442-546_2ce787d5-a3e1-4202-a051-e15771441812
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA077355
Listing Expiration 2026-12-31
Marketing Start 2025-09-02

Pharmacologic Class

Established (EPC)
histamine-2 receptor antagonist [epc]
Mechanism of Action
histamine h2 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 82442546
Hyphenated Format 82442-546

Supplemental Identifiers

RxCUI
283641
UNII
H0G9379FGK 5QZO15J2Z8 NBZ3QY004S
NUI
N0000000151 N0000175784

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name up and up dual action acid reducer and antacid (source: ndc)
Generic Name famotidine, calcium carbonate, magnesium hydroxide (source: ndc)
Application Number ANDA077355 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 800 mg/1
  • 10 mg/1
  • 165 mg/1
source: ndc
Packaging
  • 50 TABLET, CHEWABLE in 1 BOTTLE (82442-546-71)
source: ndc

Packages (1)

82442-546-71 50 TABLET, CHEWABLE in 1 BOTTLE (82442-546-71)

Ingredients (3)

calcium carbonate (800 mg/1) famotidine (10 mg/1) magnesium hydroxide (165 mg/1)

Linked Drug Pages (1)

Up and Up Dual Action Acid Reducer and Antacid ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2ce787d5-a3e1-4202-a051-e15771441812", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["H0G9379FGK", "5QZO15J2Z8", "NBZ3QY004S"], "rxcui": ["283641"], "spl_set_id": ["2f020677-77a0-4e13-9397-e9deeda63293"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Target Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 TABLET, CHEWABLE in 1 BOTTLE (82442-546-71)", "package_ndc": "82442-546-71", "marketing_start_date": "20250902"}], "brand_name": "Up and Up Dual Action Acid Reducer and Antacid", "product_id": "82442-546_2ce787d5-a3e1-4202-a051-e15771441812", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Calculi Dissolution Agent [EPC]", "Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "82442-546", "generic_name": "Famotidine, Calcium Carbonate, Magnesium Hydroxide", "labeler_name": "Target Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Up and Up Dual Action Acid Reducer and Antacid", "active_ingredients": [{"name": "CALCIUM CARBONATE", "strength": "800 mg/1"}, {"name": "FAMOTIDINE", "strength": "10 mg/1"}, {"name": "MAGNESIUM HYDROXIDE", "strength": "165 mg/1"}], "application_number": "ANDA077355", "marketing_category": "ANDA", "marketing_start_date": "20250902", "listing_expiration_date": "20261231"}